Cargando…
S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428241/ http://dx.doi.org/10.1097/01.HS9.0000968116.45317.31 |
| _version_ | 1785090420308443136 |
|---|---|
| author | Kenet, Gili Nolan, Beatrice Zulfikar, Bulent Antmen, Bulent Young, Guy Chi, Jiarui Afonso, Marion Cano, Viridiana Sussebach, Christian Andersson, Shauna Kavakli, Kaan |
| author_facet | Kenet, Gili Nolan, Beatrice Zulfikar, Bulent Antmen, Bulent Young, Guy Chi, Jiarui Afonso, Marion Cano, Viridiana Sussebach, Christian Andersson, Shauna Kavakli, Kaan |
| author_sort | Kenet, Gili |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428241 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282412023-08-17 S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX Kenet, Gili Nolan, Beatrice Zulfikar, Bulent Antmen, Bulent Young, Guy Chi, Jiarui Afonso, Marion Cano, Viridiana Sussebach, Christian Andersson, Shauna Kavakli, Kaan Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428241/ http://dx.doi.org/10.1097/01.HS9.0000968116.45317.31 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Kenet, Gili Nolan, Beatrice Zulfikar, Bulent Antmen, Bulent Young, Guy Chi, Jiarui Afonso, Marion Cano, Viridiana Sussebach, Christian Andersson, Shauna Kavakli, Kaan S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title | S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title_full | S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title_fullStr | S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title_full_unstemmed | S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title_short | S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX |
| title_sort | s301: consumption of factor concentrates and bypassing agents for management of breakthrough bleeds with fitusiran prophylaxis in people with haemophilia a or b: analysis of atlas-ppx |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428241/ http://dx.doi.org/10.1097/01.HS9.0000968116.45317.31 |
| work_keys_str_mv | AT kenetgili s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT nolanbeatrice s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT zulfikarbulent s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT antmenbulent s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT youngguy s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT chijiarui s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT afonsomarion s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT canoviridiana s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT sussebachchristian s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT anderssonshauna s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx AT kavaklikaan s301consumptionoffactorconcentratesandbypassingagentsformanagementofbreakthroughbleedswithfitusiranprophylaxisinpeoplewithhaemophiliaaorbanalysisofatlasppx |